Ann: Trading Halt, page-42

  1. 1,419 Posts.
    lightbulb Created with Sketch.  84
    Revenue is what people want to see. Current market cap is approx $9.8m and Epichem is expected to make $4m this FY. The deal with Elanco removes a lot of the financial burden of running the clinical trials so the cash position of the company is enough to sustain current operations.

    I can't explain why people are selling but I know why I am buying.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.